Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests to detect cancers early by measuring enzyme activity.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Urteste S.A. is a research and development company specializing in innovative in vitro diagnostic (IVD) medical devices. The company focuses on creating a pioneering technology for the early detection of multiple types of cancer from a single, non-invasive urine sample. Its proprietary method is based on measuring the activity of specific enzymes to identify malignancies at an early stage, with the goal of substantially increasing patient survival rates. The company's development pipeline includes diagnostic tests for various cancers, such as the Panuri Test for pancreatic cancer and a test for breast cancer.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 16:00
Share Issue/Capital Change
OPINIA ZARZĄDU uzasadniająca powody pozbawienia akcjonariuszy prawa poboru akcji
Polish 178.5 KB
2025-11-07 16:00
Post-Annual General Meeting Information
Projekty uchwał
Polish 229.9 KB
2025-11-07 16:00
Proxy Solicitation & Information Statement
Pełnomocnictwo udzielane przez osoby prawne do uczestnictwa
Polish 160.7 KB
2025-11-07 16:00
Regulatory News Service
Pełnomocnictwo udzielane przez osoby fizyczne do uczestnictwa
Polish 156.4 KB
2025-11-07 16:00
Regulatory News Service
INFORMACJE DOTYCZĄCE PRZETWARZANIA DANYCH OSOBOWYCH AKCJONARIUSZY I PEŁNOMOCNIK…
Polish 191.5 KB
2025-11-07 16:00
Declaration of Voting Results & Voting Rights Announcements
INFORMACJA o ogólnej liczbie akcji w Spółce Urteste S.A.
Polish 118.9 KB
2025-11-07 16:00
Regulatory News Service
FORMULARZ pozwalający na wykonywanie prawa głosu przez pełnomocnika
Polish 284.9 KB
2025-11-07 16:00
Pre-Annual General Meeting Information
Ogłoszenie Zarządu Urteste S.A.
Polish 217.3 KB
2025-11-07 16:00
Pre-Annual General Meeting Information
Zwołanie Nadzwyczajnego Walnego Zgromadzenia na dzień 4 grudnia 2025 roku - Con…
Polish 1.5 KB
2025-11-07 10:36
Share Issue/Capital Change
Zawarcie dwóch umów inwestycyjnych dotyczących dokapitalizowania Spółki - Conte…
Polish 2.6 KB
2025-10-31 10:46
Legal Proceedings Report
Zawarcie umowy z firmą typu CRO - rozpoczęcie wieloośrodkowego badania kliniczn…
Polish 3.2 KB
2025-10-20 17:09
Capital/Financing Update
Zawarcie umowy pożyczki - Content (PL)
Polish 1.4 KB
2025-09-29 17:38
Audit Report / Information
Opinia biegłego
Polish 366.5 KB
2025-09-29 17:38
Management Discussion and Analysis
Sprawozdanie z działalności Zarządu za I półrocze 2025
Polish 1.0 MB
2025-09-29 17:38
Interim Report
Sprawozdanie finansowe za I półrocze 2025
Polish 1.2 MB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Urteste S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.